News 3 March 2022 Liver Cancer, Phase 1b Clinical results publication Major First in Class Clinical data! Genoscience is proud to announce a new cornerstone of…Read More
News 17 January 2022 GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition Since December 2019, SARS-CoV-2 has spread quickly worldwide, leading to more than 280 million confirmed…Read More
News 17 December 2021 GENOSCIENCE PHARMA out licenses rights of GNS561 in Europe, US and Canada territories in Cholangiocarcinoma Genoscience is proud to announce the out-licensing of GNS561 in the cholangiocarcinoma in the United…Read More
News 8 November 2021 GNS561, a clinical-stage PPT1 inhibitor is efficient against Hepatocarcinoma via modulation of lysosomal functions The Genoscience Pharma's team and its collaborators are happy of this new publication in Autophagy…Read More
News 13 September 2021 GNS561, active against Cancer Stem Cells. A new article has been recently published in the #journalofcancer showing that #GNS561, a new #autophagy blocker, offers great…Read More
News Nov. 18, 2020 GNS561’s successful phase 1b trial completed Genoscience Pharma completes successful phase 1b trial evaluating GNS561, PPT-1 inhibitor, in patients with primary…Read More
News July 22, 2020 GNS561, a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition Marseille, July 22, 2020_ Therapeutic Advances in Chronic disease just published Genoscience Pharma's article E…Read More
News 18 June, 2020 Our COVID-19 research Project supported by the French Government Marseille, June 18, 2020_ The French Government announced in today's press release that Genoscience Pharma…Read More
News April 6, 2020 COVID-19, GNS561’s Assault begins in France ! Marseille, April 6, 2020 — Genoscience Pharma Starts a phase 2 multicenter study using GNS561,…Read More
News January 13, 2020 ISO9001:2015 Certification for our R&D and Clinical Activities in Oncology Marseille, January 13, 2020 - Genoscience Pharma, a clinical-stage biotechnology company dedicated to discovering and…Read More